Xiao-qing Sun
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Empagliflozin Ameliorates Experimental Pulmonary Vascular Remodeling, but May Not Benefit Patients With Pulmonary Arterial Hypertension.
Journal: Journal of the American Heart Association
Published: July 25, 2026
Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in mice.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: May 29, 2024
Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
Journal: American journal of respiratory cell and molecular biology
Published: December 02, 2020
MnTBAP Reverses Pulmonary Vascular Remodeling and Improves Cardiac Function in Experimentally Induced Pulmonary Arterial Hypertension.
Journal: International journal of molecular sciences
Published: April 21, 2020
Emphysema Is-at the Most-Only a Mild Phenotype in the Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: August 23, 2019
Effects of 6-mercaptopurine in pressure overload induced right heart failure.
Journal: PloS one
Published: July 19, 2019
Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signalling.
Journal: The European respiratory journal
Published: December 18, 2018
Role of cardiac inflammation in right ventricular failure.
Journal: Cardiovascular research
Published: March 20, 2017
Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
Journal: Circulation
Published: January 18, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026